Transmission and Acquisition of Nontuberculous Mycobacteria Outbreak Investigation (TrANsMIt)
NCT06155747 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-05-26
Summary
The goal of this observational study is to support U.S. healthcare centers in determining if they may have an NTM outbreak among patients receiving care at the healthcare center. The study applies a standardized, reproducible outbreak investigation approach across diverse healthcare settings. This study focuses on patients with NTM isolates suspected to be part of an outbreak, receiving care at a specific U.S. healthcare center.
The main questions it aims to answer are:
Can application of a standardized epidemiologic investigation framework support evaluation of whether clustered NTM infections may be consistent with healthcare-associated exposure? Are respiratory NTM isolates genetically related to environmental NTM isolates identified within healthcare settings or shared home water sources?
Researchers will compare clinical, epidemiologic, molecular, and infection prevention data from suspected NTM isolates to determine whether patterns are consistent with healthcare-associated transmission or acquisition.
Participants (healthcare centers and selected patients) will:
* Implement a standardized epidemiologic investigation using the Healthcare-Associated Links in Transmission of Nontuberculous Mycobacteria (HALT-NTM) toolkit
* Submit available respiratory and environmental NTM isolates for molecular comparison, when applicable
* Optionally collect dust and water biofilm samples within the healthcare setting
* Complete a survey to provide home address history for watershed mapping, when clustered infections are identified
Conditions
- Nontuberculous Mycobacterial Pulmonary Infection
- Outbreak Investigation
- Healthcare Associated Infection
- Mycobacterium Infections
Interventions
- OTHER
-
Epidemiologic investigation
Identification of: 1. overlaps in source(s) of care between participants with NTM isolates in a healthcare center. 2. environmental NTM isolates that are highly related to respiratory isolates. 3. common water source exposure among subjects with clustered NTM infections via shared home of residence watershed.
Sponsors & Collaborators
-
National Jewish Health
collaborator OTHER -
University of Texas at Tyler
collaborator OTHER -
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Jane Gross, MD, PhD · University of North Carolina, Chapel Hill
Eligibility
- Min Age
- 1 Month
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2036-12-28
- Completion
- 2036-12-28
Countries
- United States
Study Locations
More Related Trials
-
Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection
NCT02225158 ·Status: TERMINATED
-
Prospective Cohort of People Starting Treatment for Tuberculosis Disease in France (FrenchTB)
NCT06893757 ·Status: NOT_YET_RECRUITING
-
Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests
NCT02252198 ·Status: COMPLETED
-
Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens
NCT05871489 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Evaluation of the NanoDetect-TB Mycobacterium Tuberculosis Detection Kit for the Diagnosis of Tuberculosis Disease
NCT05981495 ·Status: UNKNOWN
-
Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission
NCT02355223 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects
NCT01587469 ·Status: COMPLETED
-
Improving the Diagnostic of Tuberculosis
NCT02861768 ·Status: COMPLETED ·Phase: NA
-
Tuberculosis as a Risk Factor for a Worse Outcome Post-Sars-CoV-2 Infection
NCT05643781 ·Status: COMPLETED
-
Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial
NCT05017324 ·Status: UNKNOWN ·Phase: NA
-
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis
NCT06058299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis
NCT05555303 ·Status: RECRUITING ·Phase: PHASE2
-
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
NCT06764576 ·Status: RECRUITING
-
Expression of Tuberculosis in the Lung
NCT00201253 ·Status: COMPLETED
-
Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis
NCT00926601 ·Status: UNKNOWN
-
Time-to-Detection in Culture of Mycobacterium Tuberculosis
NCT05568368 ·Status: COMPLETED
-
Clinic-based Versus Hotspot-focused Active TB Case Finding
NCT05285202 ·Status: RECRUITING ·Phase: NA
-
Comparison Between Two Strategies for the Diagnosis of TB
NCT02961569 ·Status: COMPLETED ·Phase: NA
-
Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients
NCT05148949 ·Status: UNKNOWN ·Phase: PHASE4
-
Azithromycin as Host-directed Therapy for Pulmonary Tuberculosis
NCT03160638 ·Status: COMPLETED ·Phase: PHASE2
-
DeMONSTRATE-TB Study in Ethiopia
NCT06719193 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design
NCT01785186 ·Status: COMPLETED ·Phase: PHASE2
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Tuberculosis in a Multiethnic Inner City Population
NCT00005379 ·Status: COMPLETED
-
Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)
NCT05280886 ·Status: UNKNOWN